In the rapidly evolving field of RNA therapeutics, the choice of nucleoside modification and solid support is critical for ensuring yield, purity, and biological activity. rA(Ac) (N6-Acetyl-adenosine) has emerged as a preferred building block, particularly when integrated into Controlled Pore Glass (CPG) solid supports.
1. Chemical Profile: What is rA(Ac)?
rA(Ac) refers to adenosine where the exocyclic amino group at the N6 position is modified with an Acetyl (Ac) group.Natural Significance (ac6A)
As a natural epigenetic modification, ac6A influences RNA stability and translation efficiency.Synthetic Utility
In the context of phosphoramidite chemistry, the Acetyl group serves as a sophisticated protecting group for the highly reactive adenine base.2. Strategic Advantages in Solid-Phase Synthesis
The use of rA(Ac) CPG offers distinct operational benefits over traditional protection schemes like Benzoyl (Bz).A. Mild and Rapid Deprotection
The Acetyl group is significantly more labile than the Benzoyl group.Kinetic Advantage
It allows for faster cleavage and deprotection during the ammonia or methylamine treatment phase.Preserving RNA Integrity
Because deprotection can occur at lower temperatures or for shorter durations, the risk of RNA backbone degradation (uracil cleavage or chain fragmentation) is minimized.B. High-Throughput & Long-Chain Efficiency
For modern automated synthesizers, rA(Ac) monomers and CPGs optimize the synthesis cycle:- Improved Coupling: Higher reaction rates lead to better step-wise yields.
- Enhanced Purity: Reducing side reactions during the synthesis of long-chain RNA leads to a cleaner crude product.
3. Key Applications in RNA Therapeutics
rA(Ac) CPG is the industry standard for specific classes of oligonucleotides where 3′ adenosine initiation is required.A. siRNA (Small Interfering RNA) —— Highly Standardized
siRNA molecules typically feature 2-nucleotide 3′ overhangs to facilitate the RISC loading process.Overhang Initiation
If the 3′ terminal nucleotide is Adenosine, rA(Ac) CPG is the required starting point.Bioactivity Preservation
The mild deprotection enabled by the Acetyl group ensures that the delicate double-stranded structure and any 2′-O-modifications remain intact, which is vital for gene silencing potency.B. gRNA (guide RNA for CRISPR/Cas9) —— Precision Synthesis
Single guide RNAs (sgRNA) are relatively long sequences, often exceeding 100 nucleotides.Sequence Fidelity
For such long sequences, even a 1% drop in coupling efficiency can lead to a significant loss of final product. rA(Ac) CPG provides the high coupling efficiency necessary for long-chain fidelity.Purification Efficiency
The higher crude purity (often reaching ~80% before purification) significantly reduces the burden on downstream HPLC or PAGE purification processes.4. Why Use Co-Polymer Coated rA(Ac) CPG?
In large-scale GMP production,our patented co-polymer coating technology is to address industrial bottlenecks:- Ultra-High Loading: Delivers 3–6× the capacity of conventional supports (up to 240 μmol/g), maximizing output per batch.
- Physical Robustness: The coating prevents “silica shedding” and column clogging, ensuring consistent flow rates during high-pressure industrial runs.
- Chemical Stability: It provides a protective environment that shields the rA(Ac) linkage from premature cleavage during the acidic detritylation steps of the synthesis cycle.
- Long-Chain Oligonucleotide:Our 2000Å co-polymer coated CPG solid support enables efficient synthesis of long oligos (>100 nt, e.g., sgRNA), delivering higher loading capacity, yield, OD value, and purity than traditional CPG.
Why Choose Our Co-Polymer Coated rA(Ac)-CPG?
The Industrial Standard for High-Yield & High-Purity RNA Synthesis
In large-scale GMP production of siRNA, gRNA, and long-chain RNA fragments, the choice of solid support defines your process efficiency. Our rA(Ac) Co-Polymer Coated CPG combines the structural rigidity of inorganic silica with the high-loading versatility of advanced organic polymers.1. Ultra-High Loading Capacity: 3–6× Higher Output
Traditional CPG often forces a trade-off between pore size and loading density. Our proprietary co-polymer coating breaks this limit, delivering significantly higher micromoles of rA(Ac) per gram of support.Massive Productivity
Increase your RNA oligonucleotide output per batch without increasing column size.Optimized for All Lengths:
500 Å
200 ~ 240 μmol/g
Ideal for short siRNA/ASO
1000 Å
100 ~ 150 μmol/g
The “Sweet Spot” for gRNA
2000 Å
40 ~ 80 μmol/g
Optimized for long RNA >100 nt
2. Superior Crude Purity (Up to 80%)
The co-polymer shield protects the rA(Ac) linkage and the growing oligonucleotide chain from harsh reagent cycles.Chemical Resilience
Exceptional resistance to acidic detritylation (TCA/DCA), basic deprotection (Ammonia/Methylamine), and aggressive organic solvents.Reduced Downstream Burden
By achieving ~80% crude purity, you significantly reduce the complexity and cost of HPLC/IEX purification, accelerating your CMC timelines.3. Rock-Solid Physical Stability for GMP Scaling
Unlike pure polystyrene resins that suffer from “swelling” in organic solvents (causing pressure spikes), our rigid CPG core remains dimensionally stable.Consistent Flow Dynamics
Ensures uniform reagent distribution across the bed, even at high flow rates.Zero Bed Compression
Critical for maintaining reproducible synthesis cycles in large-scale industrial synthesizers.4. Advanced Surface Stabilization: No Silica Shedding
Silica “fines” or shedding can lead to column clogging and increased backpressure, a common failure point in long-sequence synthesis.Co-Polymer Encapsulation
The coating tightly binds the CPG surface, virtually eliminating particle shedding.Extended Hardware Life
Protects your high-performance synthesis valves and lines from abrasive silica dust.5. Optimized rA(Ac) Chemistry for Sensitive RNA
We utilize the N6-Acetyl (Ac) protection group specifically for its fast-deprotection kinetics.Gentle Cleavage
rA(Ac) allows for milder deprotection conditions compared to Benzoyl (Bz) groups, preserving the integrity of sensitive 2′-O-modifications or dye labels often used in siRNA and gRNA therapeutics.Applications at a Glance
siRNA gRNA (CRISPR) mRNA Fragments
- siRNA: Maximize batch yields for therapeutic interference.
- gRNA (CRISPR): Reliable synthesis of 100+ nt sequences with high fidelity.
- mRNA Fragments: Ideal for the synthesis of complex starting materials for enzymatic ligation.
Are you looking to optimize a specific scale (e.g., 50 mmol+) or a particular sequence length? We can provide customized loading specifications to match your synthesizer’s pressure profile.
Reviews
There are no reviews yet.